Endoscopic Retrograde Cholangiopancreatography in Diagnosis and Treatment of Primary Sclerosing Cholangitis

Clinics in Liver Disease

Volumn 14, Issue 2, 2010, Pages 349-358

  Gotthardt, Daniel ^a   Stiehl, Adolf ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cholangiocarcinoma; Dominant stenosis; Endoscopic retrograde cholangiopancreatography; Endoscopic therapy; Sclerosing cholangitis

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; GAMMA GLUTAMYLTRANSFERASE; METRONIDAZOLE; MONOCYCLINE; UNCLASSIFIED DRUG;

BALLOON DILATATION; CHOLEDOCHOJEJUNOSTOMY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPY; ENZYME BLOOD LEVEL; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LIVER TRANSPLANTATION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; SENSITIVITY AND SPECIFICITY; SPHINCTEROTOMY;

BALLOON DILATION; BILE DUCTS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CHOLANGITIS, SCLEROSING; CONSTRICTION, PATHOLOGIC; EARLY DETECTION OF CANCER; HUMANS; STENTS;

EID: 77952976622     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2010.03.010     Document Type: Review

References (51)

1. Chapman R.W., Arborgh B.A., Rhodes J.M., et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 21 (1980) 870
2. Wiesner R.H., Grambsch P.M., Dickson E.R., et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 10 (1989) 430
3. Farrant J.M., Hayllar K.M., Wilkinson M.L., et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 100 (1991) 1710
4. Broome U., Olsson R., Loof L., et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38 (1996) 610
5. Fulcher A.S., Turner M.A., Franklin K.J., et al. Primary sclerosing cholangitis: evaluation with MR cholangiography-a case-control study. Radiology 215 (2000) 71
6. Angulo P., Pearce D.H., Johnson C.D., et al. Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis. J Hepatol 33 (2000) 520
7. Textor H.J., Flacke S., Pauleit D., et al. Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography. Endoscopy 34 (2002) 984
8. Weber C., Kuhlencordt R., Grotelueschen R., et al. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis. Endoscopy 40 (2008) 739
9. Stiehl A., Rudolph G., Sauer P., et al. Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol 26 (1997) 560
10. Stiehl A., Rudolph G., Kloters-Plachky P., et al. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol 36 (2002) 151
11. Tischendorf J.J., Hecker H., Kruger M., et al. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol 102 (2007) 107
12. Bjornsson E., Lindqvist-Ottosson J., Asztely M., et al. Dominant strictures in patients with primary sclerosing cholangitis. Am J Gastroenterol 99 (2004) 502
13. Gluck M., Cantone N.R., Brandabur J.J., et al. A twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis. J Clin Gastroenterol 42 (2008) 1032
14. Grijm R., Huibregtse K., Bartelsman J., et al. Therapeutic investigations in primary sclerosing cholangitis. Dig Dis Sci 31 (1986) 792
15. Johnson G.K., Geenen J.E., Venu R.P., et al. Endoscopic treatment of biliary duct strictures in sclerosing cholangitis: follow-up assessment of a new therapeutic approach. Gastrointest Endosc 33 (1987) 9
16. Cotton P.B., and Nickl N. Endoscopic and radiologic approaches to therapy in primary sclerosing cholangitis. Semin Liver Dis 11 (1991) 40
17. Gaing A.A., Geders J.M., Cohen S.A., et al. Endoscopic management of primary sclerosing cholangitis: review, and report of an open series. Am J Gastroenterol 88 (1993) 2000
18. Lee J.G., Schutz S.M., England R.E., et al. Endoscopic therapy of sclerosing cholangitis. Hepatology 21 (1995) 661
19. van Milligen de Wit A.W., van Bracht J., Rauws E.A., et al. Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest Endosc 44 (1996) 293
20. Wagner S., Gebel M., Meier P., et al. Endoscopic management of biliary tract strictures in primary sclerosing cholangitis. Endoscopy 28 (1996) 546
21. Kaya M., Petersen B.T., Angulo P., et al. Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis. Am J Gastroenterol 96 (2001) 1059
22. Baluyut A.R., Sherman S., Lehman G.A., et al. Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. Gastrointest Endosc 53 (2001) 308
23. May G.R., Bender C.E., LaRusso N.F., et al. Nonoperative dilatation of dominant strictures in primary sclerosing cholangitis. AJR Am J Roentgenol 145 (1985) 1061
24. Bangarulingam S.Y., Gossard A.A., Petersen B.T., et al. Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis. Am J Gastroenterol 104 (2009) 855-860
25. Farges O., Malassagne B., Sebagh M., et al. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery 117 (1995) 146
26. Olsson R., Bjornsson E., Backman L., et al. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J Hepatol 28 (1998) 426
27. Pohl J., Ring A., Stremmel W., et al. The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 18 (2006) 69
28. Hammel P., Couvelard A., O'Toole D., et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 344 (2001) 418
29. Kulaksiz H., Weiss K.H., Gotthardt D., et al. Is stenting necessary after balloon dilation of post-transplantation biliary strictures? Results of a prospective comparative study. Endoscopy 40 (2008) 746
30. Ponsioen C.Y., Lam K., van Milligen de Wit A.W., et al. Four years experience with short term stenting in primary sclerosing cholangitis. Am J Gastroenterol 94 (1999) 2403
31. Gotthardt D.N., Rudolph G., Klöters-Plachky P., et al. Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. Gastrointest Endosc 71 (2010) 527-534
32. Rudolph G., Gotthardt D., Kloters-Plachky P., et al. Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. J Hepatol 51 (2009) 149-155
33. Farkkila M., Karvonen A.L., Nurmi H., et al. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial. Hepatology 40 (2004) 1379
34. Hultcrantz R., Olsson R., Danielsson A., et al. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol 30 (1999) 669
35. Keiding S., Hansen S.B., Rasmussen H.H., et al. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 28 (1998) 700
36. Kluge R., Schmidt F., Caca K., et al. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 33 (2001) 1029
37. Ponsioen C.Y., Vrouenraets S.M., van Milligen de Wit A.W., et al. Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy 31 (1999) 305
38. Boberg K.M., Jebsen P., Clausen O.P., et al. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol 45 (2006) 568
39. Charatcharoenwitthaya P., Enders F.B., Halling K.C., et al. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 48 (2008) 1106
40. Rudolph G., Kloeters-Plachky P., Rost D., et al. The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid. Eur J Gastroenterol Hepatol 19 (2007) 487
41. Burak K., Angulo P., Pasha T.M., et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 99 (2004) 523
42. Beuers U., Spengler U., Kruis W., et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 16 (1992) 707
43. Stiehl A., Walker S., Stiehl L., et al. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. J Hepatol 20 (1994) 57
44. Mitchell S.A., Bansi D.S., Hunt N., et al. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 121 (2001) 900
45. Lindor K.D. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. N Engl J Med 336 (1997) 691
46. Harnois D.M., Angulo P., Jorgensen R.A., et al. High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis. Am J Gastroenterol 96 (2001) 1558
47. Cullen S.N., Rust C., Fleming K., et al. High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective. J Hepatol 48 (2008) 792
48. Lindor K.D., Enders F.B., Schmoll J.A., et al. Randomized, double-blind controlled trial of high-dose ursodeoxycholic acid (UDCA) for primary sclerosing cholangitis (PSC). Hepatology 48 (2008) LB2
49. Silveira M.G., Torok N.J., Gossard A.A., et al. Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study. Am J Gastroenterol 104 (2009) 83
50. Alabraba E., Nightingale P., Gunson B., et al. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl 15 (2009) 330
51. Berstad A.E., Aabakken L., Smith H.J., et al. Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis. Clin Gastroenterol Hepatol 4 (2006) 514